!

URGENT: SB 432, which will enable Big Pharma to raise drug costs even higher, just moved one step closer to passing. 

Take Action: Email Your Legislator to Stop Big Pharma’s Latest Price Gouging Move

June 20, 2019

We’ve told you about big Pharma’s brazen attempt to gut one of the last remaining protection for patients against runaway drug prices.

Now the most profitable industry in the world is quietly pushing a bill through the state legislature that would cripple pharmacy benefit managers (PBMs), which negotiate lower drug costs for North Carolinians.

The powerful pharmaceutical lobby knows that the public is furious about rising drug costs.  They have been trying to put the blame on PBMs - despite the fact that PBMs job is to represent the financial interests of patients in the negotiation. But we know that only one party sets list price of drugs and that is the pharmaceutical manufacturers themselves. 

We cannot let big pharma use the law to eliminate our only advocate in price negotiations. 

Here’s what you can do to help: Write your legislator and ask them to oppose the language in HB 534.

!
Action Needed

Tell your representative to say "no" to higher drug costs

We’ve told you about big Pharma’s brazen attempt to gut the last remaining protection for patients against runaway drug prices.

Now the most profitable industry in the world is quietly pushing a bill through the state legislature that would cripple pharmacy benefit managers (PBMs), which negotiate lower drug costs for North Carolinians.

We cannot let big pharma use the law to eliminate our only advocate in price negotiations.


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Federal Judge’s Ruling Deals Blow to Quest for Drug Price Transparency
AARP: Specialty Drug Costs Greatly Exceeding Median U.S. Household Income
Pharma Company Increases Drug Price by 909% as Wholesale Rates Soar

Featured Articles

Tell your representative to say "no" to higher drug costs
SB 432 – Lots of Treats for Pharmacists – and Bad News for Consumers
Why do Pharmaceutical Companies hate PBMs so much?
AARP: Specialty Drug Costs Greatly Exceeding Median U.S. Household Income
Pharma Company Increases Drug Price by 909% as Wholesale Rates Soar
Podcast: Senator Joyce Krawiec Talks to Us About Why CON Laws are Bad for NC